Skip to main content
SpringerLink
Log in

Antiepileptic Agents

  • Chapter
  • First Online:
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care

  • 4678 Accesses

Abstract

This chapter provides an overview of the currently available antiepileptic drugs. At this time, there are 24 antiepileptic drugs approved by the FDA, several only recently. Some drugs have more than one mechanism of action. Some of these agents have only one particular indication, while others have a broad spectrum of action. A few are approved only for adjunct therapy. A common classification is by generation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sirven JI, Noe K, Hoerth M, Drazkowski J. Antieplileptic drugs 2012: recent advances and trends. Mayo Clin Proc. 2012;87(9):879–89.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Ochoa JG, Benbadi SR, Riche W, Passaro EA, Talavera F. Antiepileptic drugs. Medscape Reference © 2011 WebMD, LLC [updated 25 Oct 2012]

    Google Scholar 

  3. Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46(Suppl 4):31-37

    Google Scholar 

  4. White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007;81:85–110.

    Article  CAS  PubMed  Google Scholar 

  5. Woelfel JA, Cupp M. Comparison of antiepileptic drugs. Pharmacist’s Letter/Prescriber’s Letter, Detail-Document #250707. 2009;25#250707:1–24

    Google Scholar 

  6. Brunton LL, Chabner B, Knollman BC. 12e. Section 2. Neuropharmacology. Chapter 21. Pharmacotherapy of the epilepsies. In: Goodman and Gilman’s pharmacological basis of therapeutics. New York: McGraw-Hill; 2011.

    Google Scholar 

  7. Perucca P, Mula M. Antiepileptic drug effects on mood and behavior: molecular targets. Epilepsy Behav. 2012. Available from: http://dx.doi.org/10.1016/j.yebeh.2012.09.018.

  8. Hung C, Chen JW. Treatment of post-traumatic epilepsy. Curr Treat Options Neurol. 2012;14:293–306.

    Article  PubMed  Google Scholar 

  9. Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9:68–82.

    Article  CAS  PubMed  Google Scholar 

  10. Cavazos JE, Benbadis SR, Diaz-Arrastia R, Spitz M, Talavera F. Epilepsy and seizures. Medscape Reference ©2011WebMD, LLC [updated 25 Oct 2012]

    Google Scholar 

  11. Wang SP, Mintzer S, Skidmore CT, Zhan T, Stuckert E, Nei M, et al. Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia. 2013;54:187–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Löscher W, Schmidt D. Perampanel – new promise for refractory epilepsy? Nat Rev Neurol. 2012;13:1–2.

    Article  Google Scholar 

  13. Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49 Suppl 9:63–73.

    Article  CAS  PubMed  Google Scholar 

  14. Kleckner NW, Glazewski JC, Chen CC, Moscrip TD. Subtype-selective antagonism of N-Methyl-D-Aspartate receptors by felbamate: insights into the mechanism of action. J Pharmacol Exp Ther. 1999;289(2):886–94.

    CAS  PubMed  Google Scholar 

  15. Ohno Y, Sofue N, Imaoku T, Morishita E, Kumafuji K, Sasa M, et al. Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsy. J Pharmacol Sci. 2012;114:99–105.

    Article  Google Scholar 

  16. Ezogabine FE. A new angle on potassium gates. Epilepsy Curr. 2011;11(3):75–8.

    Article  Google Scholar 

  17. Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, et al. The synaptic vesicle protein SV2 is complexed with an α5-containing laminin on the nerve terminal surface. J Biol Chem. 2000;275(1):451–60.

    Article  CAS  PubMed  Google Scholar 

  18. Mula M, Kanner AM, Schmitz B, Schachter S. Antiepileptic drugs and suicidality: an expert consensus statement from the task force on therapeutic strategies of the ILAE commission on neuropsychobiology. Epilepsia. 2013;54:199–203.

    Article  CAS  PubMed  Google Scholar 

  19. Andersohn F, Schade R, Willich SN, Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75:335–9.

    Article  CAS  PubMed  Google Scholar 

  20. Arana A, Wentworth CE, Ayuso-Mateos JL, et al. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med. 2010;363(6):542–51.

    Article  CAS  PubMed  Google Scholar 

  21. Olesen JB, Hansen PR, Erdal J, Abildstrom SZ, Weeke P, Fosbol EL, et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf. 2010;19(5):518–24.

    PubMed  Google Scholar 

  22. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia. 2009;50(5):978–86.

    Article  PubMed  Google Scholar 

  23. Internet Browser, Nov 2011, available from http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm243476.htm

  24. Internet Browser, NDA 20-712/S-029 http://www.fda.gov/downloads/Drugs/DrugSafety/DrugSafetyNewsletter/UCM148014.pdf

  25. Gil-Nagel A, Elger C, Ben-Menachem E, Halász P, Lopes-Lima J, Gabbai A, et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies. Epilepsia. 2013;54:98–107.

    Article  CAS  PubMed  Google Scholar 

  26. Dong X, Leppik IE, White J, Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology. 2005;65:1976–8.

    Article  CAS  PubMed  Google Scholar 

  27. Mazza M, Marca GD, Nicola MD, Martinotti G, Pozzi G, Janiri L, et al. Oxcarbazepine improves mood in patients with epilepsy. Epilepsy Behav. 2007;10:397–401.

    Article  PubMed  Google Scholar 

  28. Ghaemi SN, Berv DA, Klugman J, Rosenquist KJ, Hsu DJ. Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry. 2003;64(8):943–5.

    Article  CAS  PubMed  Google Scholar 

  29. Internet Browser http://www.fda.gov/downloads/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm174647.pdf

  30. Tassinari CA, Michelucci R, Riguzzi P, Volpi L, Dravet C, Cano JP, et al. The use of diazepam and clonazepam in epilepsy. Epilepsia. 1998;39 Suppl 1:S7–14.

    Article  CAS  Google Scholar 

  31. Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011;77:1473–81.

    Article  CAS  PubMed  Google Scholar 

  32. Abou-Khalil B, Schmidt D. Antiepileptic drugs: advantages and disadvantages. Handb Clin Neurol. 2012;108:723–39.

    Article  PubMed  Google Scholar 

  33. Internet Browser http://www.ncbi.nlm.nih.gov/books/NBK55551/

  34. Ulloa CM, Towfigh A, Safdieh J. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatr Dis Treat. 2009;5:467–76.

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Synowiec AS, Yandora KA, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center. Epilepsy Res. 2012;98:232–7.

    Article  CAS  PubMed  Google Scholar 

  36. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2000;41 Suppl 1:S3–9.

    Article  CAS  PubMed  Google Scholar 

  37. Patsalos PN. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Epilepsia. 2005;46 Suppl 9:140–8.

    Article  CAS  PubMed  Google Scholar 

  38. Devinsky O, Faught RE, Wilder BJ, Kanner AM, Kamin M, Kramer LD, et al. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res. 1995;20:241–6.

    Article  CAS  PubMed  Google Scholar 

  39. Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA. Felbamate block of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther. 1995;273(2):878–86.

    CAS  PubMed  Google Scholar 

  40. Internet Browser https://online.epocrates.com/u/10a740/felbamate

  41. Chung S, Sperling MR, Biton V, Krauss G, Hebert D, Rudd GD, et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia. 2010;51(6):958–67.

    Article  CAS  PubMed  Google Scholar 

  42. Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. Intravenous lacosamide in refractory nonconvulsive status epilepticus. Seizure. 2012;21:198–201.

    Article  CAS  PubMed  Google Scholar 

  43. Miró J, Toledo M, Santamarina E, Ricciardi AC, Villanueva V, Pato A, et al. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study. Seizure [Internet]. 2012. Available from: http://dx.doi.org/10.1016/j.seizure.2012.10.004.

  44. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia. 2007;48(7):1308–17.

    Article  CAS  PubMed  Google Scholar 

  45. Errington AC, Coyne L, Stöhr T, Selve N, Lees G. Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology. 2006;50:1016–29.

    Article  CAS  PubMed  Google Scholar 

  46. Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, et al. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia. 2009;50(8):1899–909.

    Article  CAS  PubMed  Google Scholar 

  47. Dean C, Mosier M, Penry K. Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia. 1999;40(1):74–82.

    Article  CAS  PubMed  Google Scholar 

  48. Internet Browser http://sabril.net/hcp/vision_loss_data/other_side_effects/

  49. Perks Cheema S, Mohanraj R. Anaesthesia and epilepsy. Br J Anaesth. 2012;108(4):562–71.

    Article  Google Scholar 

  50. Perks A, Cheema S, Mohanraj R. Anaesthesia and epilepsy. Br J Anesth. 2012;108:562–71.

    Article  CAS  Google Scholar 

  51. Maranhao MVM, Gomes EA, de Carvalho PE. Epilepsy and anesthesia. Rev Bras Anestesiol. 2011;61(2):232–54.

    Article  PubMed  Google Scholar 

  52. Niesen AD, Jacob AK, Aho LE, Botten EJ, Nase KE, Nelson JM, et al. Perioperative seizures in patients with a history of a seizure disorder. Anesth Analg. 2010;111(3):729–35.

    Article  PubMed  Google Scholar 

  53. Doha NM, Rady A, El Azab SR. Preoperative use of gabapentin decreases the anesthetic and analgesic requirements in patients undergoing radical mastectomy. Egypt J Anesth. 2010;26(4):287–91.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Montefiore Medical Center, University Hospital of Albert Einstein College of Medicine of Yeshiva University, Bronx, NY, USA

    Angelika Kosse MD & Heesung Kang MD

Authors
  1. Angelika Kosse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heesung Kang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelika Kosse MD .

Editor information

Editors and Affiliations

  1. Departments of Anesthesiology and Pharmacology, LSU Health Sciences Center, New Orleans, Louisiana, USA

    Alan David Kaye

  2. Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences, Stockton, California, USA

    Adam M. Kaye

  3. Center for Perioperative Management and Medical Informatics, Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Richard D. Urman

Chemical Structures

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kosse, A., Kang, H. (2015). Antiepileptic Agents. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8948-1_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8947-4

  • Online ISBN: 978-1-4614-8948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation